
Overview
Servier Polska Services is involved in the development and production of original pharmaceuticals, focusing on three therapeutic areas: cardiometabolism, oncology, and neurology. The company has received European Commission approval for worasydenib, a targeted molecular therapy for patients with glioma. Additionally, 98% of the active substances in Servier's original medications are manufactured within the European Union.
Financials
Revenue history (in m)
Filing timeliness
Financial statements were filed on time, on average 40 days early. All were audited by a statutory auditor.
- 202525/03/2026
- 202414/04/2025
- 202310/04/2024
- 202213/04/2023
- 202112/04/2022
- 202021/12/2020
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News

Servier Polska Strategic Partner of Polish Cardiology 2026

Polish Cardiac Society Research Grant 2026 Awarded in Cooperation with Servier

Servier Polska Joins the "Inclusive in Employment" Coalition

20 Years of the "Crystal Pens" Contest – Winners of the Jubilee Edition of the Nationwide Journalism Competition Announced
Industry
- Warehousing and storage of goods (52.1)
Offer
- Prescription medicines
- Oncology medicines
- Medicinal products
- Clinical trials
- Medical information
Websites
- servier.plStrona główna – Servier PolskaWordPress 6.7Yoast SEOApache
Public procurement
960 tenders recorded as contractor: 193 national ($6,888,530) and 767 EU ($115,102,483).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Nov 17, 2026 | Supply of medicines and compounding accessories | $3,702$3,702 | Samodzielny Publiczny Zakład Opieki Zdrowotnej Wojewódzki Szpital Zespolony Im. Jędrzeja Śniadeckiego w Białymstoku | |
| Nov 16, 2026 | Supply of medicines and compounding accessories | $3,702$3,702 | Samodzielny Publiczny Zakład Opieki Zdrowotnej Wojewódzki Szpital Zespolony Im. Jędrzeja Śniadeckiego w Białymstoku | |
| Nov 13, 2026 | Successive supply of medicines to the hospital pharmacy | $156$156 | Szpital w Ostródzie sp. z o.o. |
The company is the contractor in 142 public sector contracts, worth USD 5.95m in total. They were signed with 91 public buyers.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Nov 12, 2026 | Medicines . | $2,123 | Uniwersyteckie Centrum Kliniczne | |
| Nov 10, 2026 | Supply of medicines | $2,766 | Szpital Powiatowy w Chrzanowie | |
| Nov 10, 2026 | Successive supply of medicinal products for ongoing hospital pharmacotherapy, medical devices and foods for special medical purposes – Package No. 14 | $1,352 | Wojewódzki Szpital Wielospecjalistyczny Im. Dr. Jana Jonstona w Lesznie |
Job offers
The company has its own careers page: servier.pl/dolacz-do-nas.
Authorized Representatives
Manner of representation
Each member of the management board has the right to represent the company individually.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Arts Et Techniques Du Progres S.a.s. | 15,050 | $4,065,370.07 | 94.9527% |
Others | 800 | $216,099.41 | 5.0473% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2002-03-29.
- 02 1840 0007 2212 3880 0800 1719
- 84 1840 0007 2212 3880 0700 1919
74 1030 1508 0000 0008 2206 2000
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Astrazeneca Pharma Poland sp. z o.o. | $466,142,370.29 | astrazeneca.pl | ||
| Janssen-Cilag Polska sp. z o.o. | $323,933,929.12 | janssen.pl | ||
| Takeda Pharma sp. z o.o. | $246,400,594.27 | takeda.com | ||
| Biofarm sp. z o.o. | $143,422,260.45 | biofarm.pl | ||
| Zentiva Polska sp. z o.o. | $134,295,523.17 | zentiva.pl | ||
| Farmak International sp. z o.o. | $101,647,142.16 | farmakinternational.pl | ||
| Chiesi Poland sp. z o.o. | $87,762,158.97 | chiesi.com | ||
| Synoptis Pharma sp. z o.o. | $79,311,000.88 | synoptispharma.pl | ||
| Polfarmex S.A. | $73,543,379.32 | polfarmex.pl | ||
| Medac Gesellschaft Fur Klinische Spezialpraparate M.B.H. Branch (foreign co.) | $55,460,856.07 | medac.pl |
Change history
| Date | Event | |
|---|---|---|
| 2022-10-19 | Address change (Ul. Jana Kazimierza 10, 01-248, Warszawa → Ul. Burakowska 14, 01-066, Warszawa) | |
| 2015-06-01 | Address change (Annopol 6b, 03-236, Warszawa → Ul. Jana Kazimierza 10, 01-248, Warszawa) | |
| 2009-09-25 | Share capital increase (15,050,000.00 PLN → 15,850,000.00 PLN) | |
| 2005-01-10 | Share capital increase (50,000.00 PLN → 15,050,000.00 PLN) | |
| 2004-10-12 | Address change (Sienna 75, 00-833, Warszawa → Annopol 6b, 03-236, Warszawa) |
FAQ
Last updated: 2026-03-25